Pay in 4 interest-free payments of $375.00 Learn more
Ships within 48 hours · Estimated delivery Jul 26 - Jul 31
also known as MAPK3
and anti-detachment slides are used
CCL5 is an 8kDa protein classified as a chemocytokine or chemokine
Background Prefoldin subunit 2
ActRIIB Enzyme Activity Inhibitor Screening Kit Cell Biology Kits also known as MAPK3Product Specification Background STX 001, the leading program of Supercede, is a novel oral small molecule Activin Receptor Type II (ACTRII) kinase inhibitor currently in preclinical development for the treatment of obesity. In Phase II clinical studies, inhibiting the ACTRII signaling pathway has been proven to significantly reduce fat while stimulating an increase in lean body mass (muscle). For patients with obesity, achieving significant fat
US$ 30.00
US$ 25.00
US$ 10.00
US$ 130.00